Mitchell de Long
Corporate Officer/Principal en AERIE PHARMACEUTICALS, INC. .
Cargos activos de Mitchell de Long
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2005 | - |
Historial de carrera de Mitchell de Long
Antiguos cargos conocidos de Mitchell de Long.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PROCTER & GAMBLE COMPANY | Director Técnico/Científico/I+D | - | - |
Formación de Mitchell de Long.
| Stanford University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Doctorate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Consumer Services | 2 |
| Consumer Non-Durables | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
| Empresas privadas | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Mitchell de Long
- Experiencia
